Concert Financial Statements From 2010 to 2024
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
Check Concert Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concert Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Concert financial statements analysis is a perfect complement when working with Concert Pharmaceuticals Valuation or Volatility modules.
Concert |
Concert Pharmaceuticals Company Current Valuation Analysis
Concert Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Concert Pharmaceuticals Current Valuation | 86.63 M |
Most of Concert Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concert Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Concert Pharmaceuticals has a Current Valuation of 86.63 M. This is 99.4% lower than that of the Biotechnology sector and 98.14% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.48% higher than that of the company.
Concert Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Concert Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Concert Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Concert Pharmaceuticals competition to find correlations between indicators driving Concert Pharmaceuticals's intrinsic value. More Info.Concert Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Concert Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Concert Pharmaceuticals Financial Statements
Concert Pharmaceuticals stakeholders use historical fundamental indicators, such as Concert Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Concert Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Concert Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Concert Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Concert Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Concert Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |